DEGS1-associated aberrant sphingolipid metabolism impairs nervous system function in humansGergely Karsai, Ingo Kurth, Markus Bergmann et al.|Journal of Clinical Investigation|2019Cited by 129
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteinsMuseer A. Lone, Thorsten Hornemann|Journal of Clinical Investigation|2022Cited by 59
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Corinne I. Stoffel et al.|Cancer Research|2023Cited by 24
SPTLC1 variants associated with childhood onset amyotrophic lateral sclerosis produce distinct sphingolipid signatures through impaired interaction with ORMDL proteinsMuseer A. Lone, Thorsten Hornemann|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 1
Suppl. Figure S14 from ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated MelanomaOssia M. Eichhoff, Mitchell P. Levesque, Corinne I. Stoffel et al.|Unknown|2023Cited by 0